Cognitive & Neurological

Survey of GLP-1, GIP, and glucagon receptor research for metabolic signaling and incretin physiology.

Comprehensive review of BPC-157 mechanisms in tissue repair, angiogenesis, and mucosal healing.

Investigation of BDNF-promoting peptides and their mechanisms in neurotrophin signaling.

Examination of melanocortin receptor signaling and synthetic agonist research applications.

Selective Androgen Receptor Modulators (SARMs) are a class of therapeutic compounds with similar anabolic properties to anabolic steroids but with reduced androgenic activity. This article compares YK-11 and RAD-140 (Testolone), two of the most potent compounds currently discussed in sports pharmaco

Selective Androgen Receptor Modulators (SARMs) were developed to provide the therapeutic benefits of androgen replacement therapy—such as increased muscle mass and bone density—while minimizing the adverse effects associated with conventional anabolic-androgenic steroids (AAS), specifically prostate

Selective Androgen Receptor Modulators (SARMs) were developed to provide the anabolic benefits of traditional androgenic-anabolic steroids (AAS) while minimizing detrimental effects on the prostate, skin, and hair. Enobosarm (Ostarine) and Testolone (RAD-140) represent two of the most researched com

Testolone (RAD-140) is a potent, non-steroidal selective androgen receptor modulator (SARM) originally developed by Radius Health, Inc. It was designed to overcome the limitations of conventional androgen therapy, such as prostate enlargement and virilization, by exhibiting high tissue selectivity.

Pinealon is a tripeptide (Glu-Asp-Pro) bioregulator investigated for neuroprotective and cognition-supporting effects. This review summarizes in vivo evidence from animal models.

Adalank is a synthetic analog of the anxiolytic peptide Selank incorporating an adamantane moiety. This review outlines the pharmacological rationale and preclinical evidence from the Selank peptide class that informs its development.

Evidence-based review of cognitive peptide synergy, examining BDNF upregulation, neuroprotection, and synaptogenesis mechanisms.

A review of intranasal peptide delivery pharmacology, examining nasal cavity anatomy, absorption mechanisms, and bioavailability considerations.

A comparative review of peptide bioavailability across administration routes, with emphasis on intranasal delivery advantages and limitations.

A technical review of formulation parameters affecting intranasal peptide stability, absorption, and tolerability.

A technical review of intranasal peptide stability, degradation pathways, and evidence-based storage guidelines.